Literature DB >> 2581772

Bone cell phosphotyrosine phosphatase: characterization and regulation by calcitropic hormones.

J E Puzas, J S Brand.   

Abstract

Isolated bone cells in culture contain an enzyme capable of hydrolyzing the phosphate ester of phosphotyrosine. This enzyme, which we have termed phosphotyrosine phosphatase, has not previously been reported in bone. Some of its characteristics include: 1) maximum activity near physiological pH, 2) a Km for substrate of 52 microM, 3) marked inhibition by the phosphate analog vanadate ion, 4) activity correlation with bone cell alkaline phosphatase, and 5) regulation by bone target hormones. Data obtained with vanadate ion support the contention that this enzyme may play a role in the regulation of bone cell growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581772     DOI: 10.1210/endo-116-6-2463

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Phosphotyrosyl protein phosphatases.

Authors:  K H Lau; J R Farley; D J Baylink
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

2.  Vitamin D3 and avian bone in vitro: stimulation of calcium movement into Japanese quail calvaria.

Authors:  S Gunasekaran; G E Hall; A D Kenny
Journal:  Calcif Tissue Int       Date:  1986-12       Impact factor: 4.333

3.  Inflammatory cytokine gene expression in human periodontal ligament fibroblasts stimulated with bacterial lipopolysaccharides.

Authors:  Y Yamaji; T Kubota; K Sasaguri; S Sato; Y Suzuki; H Kumada; T Umemoto
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells.

Authors:  Ki Hyun Baek; Won Young Lee; Ki Won Oh; Hyun Jung Tae; Jung Min Lee; En Jung Lee; Je Ho Han; Moo Il Kang; Bong Yun Cha; Kwang Woo Lee; Ho Young Son; Sung Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

5.  Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells.

Authors:  Y Kakai; T Kawase; T Nakano; Y Mikuni-Takagaki; S Saito
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

6.  Absence of a direct anabolic effect of 17 beta-estradiol on normal human bone marrow stromal cells.

Authors:  G S Kim; S L Cheng
Journal:  Korean J Intern Med       Date:  1994-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.